News for 'Sun Pharma'

US Farm Distress Real Reason For Trump's Tariff Tantrums

US Farm Distress Real Reason For Trump's Tariff Tantrums

Rediff.com16 Sep 2025

'What the US appears to be doing is to force India to be "the buyer of last resort", on whom their products can be dumped, 1.4 billion people have to eat something, so why not eat American corn?' 'What is exercising the Trump lot is the fact that most of the farms are in solidly Republican Midwestern states: Illinois, Indiana, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, Wisconsin,' points out Rajeev Srinivasan.

Andhera Review: Absurd

Andhera Review: Absurd

Rediff.com14 Aug 2025

It is sporadically chilling but the disparate elements take forever to come together, notes Deepa Gahlot.

Apollo eyes 20-23% growth in new co; says restructuring to unlock value

Apollo eyes 20-23% growth in new co; says restructuring to unlock value

Rediff.com2 Jul 2025

Apollo Hospitals Enterprise Ltd (AHEL) on Tuesday said its ongoing restructuring aims to unlock the value of its omni-channel pharmacy and digital businesses, while enhancing shareholder returns. The newly-formed entity is expected to achieve a year-on-year growth rate of 22-23 per cent, driven by the e-pharmacy segment and other business verticals, with a revenue target of Rs 25,000 crore by the financial year 2027.

Stock markets weather Trump tariff storm

Stock markets weather Trump tariff storm

Rediff.com7 Aug 2025

Among Sensex firms, Tech Mahindra, HCL Tech, Eternal, Axis Bank, Maruti, Tata Steel, HDFC Bank and Asian Paints were the gainers. However, Adani Ports, Trent, Tata Motors, Hindustan Unilever and NTPC were among the laggards.

India, US Push To Futureproof Trade Ties

India, US Push To Futureproof Trade Ties

Rediff.com29 Jul 2025

India is seeking either an exemption or a longer timeline on the pharmaceutical tariffs, expected to kick in by July 31.

Sensex tanks 721 pts dragged by Bajaj Finance, foreign fund outflows

Sensex tanks 721 pts dragged by Bajaj Finance, foreign fund outflows

Rediff.com25 Jul 2025

Stock markets declined for the second day in a row on Friday, with the Sensex tumbling 721 points due to heavy selling in financial, IT and oil & gas shares amid persistent foreign fund outflows.

Sensex pares losses, ends up 64 points

Sensex pares losses, ends up 64 points

Rediff.com16 Jul 2025

Among Sensex firms, Mahindra & Mahindra, Tech Mahindra, State Bank of India, Infosys, Adani Ports and ITC were the major gainers. However, Eternal, Sun Pharma, Tata Steel, Tata Motors, Bajaj Finance and Bharat Electronics were among the major laggards.

Blue-chip stocks drag Sensex down by 542 points

Blue-chip stocks drag Sensex down by 542 points

Rediff.com24 Jul 2025

From the Sensex firms, Trent, Tech Mahindra, Bajaj Finserv, Reliance Industries, Infosys, Kotak Mahindra Bank, HCL Technologies, and NTPC were among the biggest laggards. However, Eternal, Tata Motors, Sun Pharma, Tata Steel, and Titan were the gainers.

Buying in L&T helps Sensex gain 144 points

Buying in L&T helps Sensex gain 144 points

Rediff.com30 Jul 2025

Sun Pharma, NTPC, Maruti, Bharti Airtel, Trent and Axis Bank were also among the gainers. However, Tata Motors, Power Grid, Eternal, Bajaj Finserv and Hindustan Unilever were among the laggards.

Can India-US Tariff Issue Be Resolved Amicably?

Can India-US Tariff Issue Be Resolved Amicably?

Rediff.com28 Aug 2025

Communication channels between India and the US are open to resolve the ongoing tariff issues, and the glitch in trade ties is only temporary, given the long-term relationship between the two nations, government sources said on Wednesday. The US' 50 per cent tariffs on Indian exports to America came into effect from August 27, barring a few sectors.

Govt to Monitor Non-Essential Drug Prices

Govt to Monitor Non-Essential Drug Prices

Rediff.com28 Jul 2025

The National Pharmaceutical Pricing Authority will monitor how companies are increasing prices of non-scheduled drugs.

Why Stock Tips Won't Build Wealth For You

Why Stock Tips Won't Build Wealth For You

Rediff.com3 Sep 2025

Real wealth isn't built on random bets; it's built on disciplined, guided portfolio strategies that can withstand market ups and downs, says Ramalingam Kalirajan.

How the markets will fare this week

How the markets will fare this week

Rediff.com27 Jul 2025

Stock markets are in for an event-heavy week ahead with a raft of Q1 earnings from blue-chips, the US Fed interest rate decision and foreign investors trading activity driving investors' sentiment, analysts said. Macroeconomic data announcements, monthly auto sales numbers and global market trends would also guide movement in the domestic equities, they said.

LIC's stock portfolio sees Rs 46,000 cr dent in July

LIC's stock portfolio sees Rs 46,000 cr dent in July

Rediff.com5 Aug 2025

Life Insurance Corporation (LIC) , the country's largest domestic institutional investor (DII), has seen a Rs 46,000 crore erosion in the value of its equity holdings amid market downturns in July. The benchmark indices, Nifty 50 and BSE Sensex, have slipped 2.6 per cent from their June 2025-end level to 24,837 and 81,463.09 respectively.

Procter & Gamble names Shailesh Jejurikar as CEO

Procter & Gamble names Shailesh Jejurikar as CEO

Rediff.com29 Jul 2025

Procter & Gamble has announced Shailesh Jejurikar as its next CEO, effective January 1, 2026. Jejurikar, an India-born executive, will succeed Jon Moeller in the role.

Weak Q4 may be rare bitter pill for Sun Pharma

Weak Q4 may be rare bitter pill for Sun Pharma

Rediff.com31 May 2024

Sun Pharmaceutical Industries reported a 34 per cent year-on-year (Y-o-Y) jump in net profit to Rs 2,654.6 crore in Q4FY24.

Sensex gains 320 points; Nifty ends above 24K

Sensex gains 320 points; Nifty ends above 24K

Rediff.com29 May 2025

Benchmark stock indices Sensex and Nifty rebounded on Thursday after two days of decline, mirroring a rally in global markets as a US court blocked President Donald Trump's reciprocal tariffs. The 30-share BSE Sensex climbed 320.70 points or 0.39 per cent to settle at 81,633.02.

Sensex decline on fag-end selling; financial stocks drag

Sensex decline on fag-end selling; financial stocks drag

Rediff.com3 Jul 2025

Among the Sensex firms, Kotak Mahindra Bank, Bajaj Finserv, Bajaj Finance, Adani Ports, Trent, State Bank of India, Titan and Tata Consultancy Services were the laggards. However, Maruti, Infosys, NTPC, Asian Paints, Eternal and Hindustan Unilever were among the biggest gainers.

T'gana plant blast: 9 still missing; cause yet to be known

T'gana plant blast: 9 still missing; cause yet to be known

Rediff.com3 Jul 2025

Nine people remain missing following the explosion at the Sigachi Industries' pharma plant in Pashamylaram, Telangana, which claimed 38 lives. An expert committee is investigating the cause of the blast.

Stock markets end lower amid Israel-Iran conflict, rising crude oil prices

Stock markets end lower amid Israel-Iran conflict, rising crude oil prices

Rediff.com17 Jun 2025

From the Sensex pack, Sun Pharma, Eternal, Tata Motors, Bajaj Finance, IndusInd Bank and Bajaj Finserv were among the major laggards. In contrast, Tech Mahindra, Infosys, Asian Paints and Maruti were among the gainers.

Trump Is Winning Tariff War Hands Down

Trump Is Winning Tariff War Hands Down

Rediff.com18 Aug 2025

Donald Trump's tariffs, meant as political punishment, have avoided the predicted chaos, lifting US growth, weakening rivals, and letting him claim victory in a resilient global economy, observes T T Ram Mohan.

Sensex, Nifty rebound nearly 1% on value buying

Sensex, Nifty rebound nearly 1% on value buying

Rediff.com16 Jun 2025

Among 30 Sensex firms, UltraTech Cement, Tech Mahindra, HCL Tech, Tata Consultancy Services, Eternal, Asian Paints, Tata Steel and Kotak Mahindra Bank were among the biggest gainers. Tata Motors, Adani Ports and Sun Pharma were the laggards.

Trump's Tariffs: Why India Needs To Be Strategic

Trump's Tariffs: Why India Needs To Be Strategic

Rediff.com12 Aug 2025

In trade negotiations, as in chess, sometimes you need to accept a temporary disadvantage to secure a better long-term position, points out Sonal Varma, chief economist (India and Asia ex-Japan) at Nomura.

Sigachi used old machinery despite requests to change, says FIR

Sigachi used old machinery despite requests to change, says FIR

Rediff.com2 Jul 2025

An FIR filed against Sigachi Industries following a fatal explosion at its Telangana unit alleges the company used outdated machinery despite warnings from employees.

Sensex gains 300 pts on fresh foreign fund inflows and buying in ICICI Bank, RIL

Sensex gains 300 pts on fresh foreign fund inflows and buying in ICICI Bank, RIL

Rediff.com27 Jun 2025

From the Sensex pack, Asian Paints, UltraTech Cement, Power Grid, ICICI Bank, Reliance Industries, Hindustan Unilever, Bharat Electronics and Sun Pharma were among the major gainers. In contrast, Trent, Eternal, Axis Bank and Titan were among the laggards.

Key factors to drive stock markets this week

Key factors to drive stock markets this week

Rediff.com6 Jul 2025

Equity investors are up for an eventful trading week ahead as the 90-day suspension period of the reciprocal tariffs announced by US President Donald Trump ends on July 9, analysts said, adding that a positive outcome from the trade negotiations could further lift market sentiment, particularly benefiting trade-sensitive sectors.

Sensex drops 345 points on weakness in IT stocks

Sensex drops 345 points on weakness in IT stocks

Rediff.com10 Jul 2025

From the Sensex pack, Bharti Airtel, Asian Paints, Infosys, Bharat Electronics, Tech Mahindra and Eternal were major laggards. However, Maruti, Tata Steel, Bajaj Finance, Bajaj Finserv, Trent and Tata Consultancy Services were among the gainers.

'Will Learning AI Help Me As An Entrepreneur?'

'Will Learning AI Help Me As An Entrepreneur?'

Rediff.com28 May 2025

Dr Ganesh Natarajan, a special guest on rediffGURUS, has been addressing questions from Rediff readers, about how to grow professionally, how women can achieve leadership roles in Indian companies, and what it takes to succeed as an entrepreneur.

Pharma cos okay with QR codes to combat counterfeit drugs

Pharma cos okay with QR codes to combat counterfeit drugs

Rediff.com19 Jul 2024

As the Drugs Controller General of India (DCGI) is set to crack down on companies to ensure compliance with printing QR codes on top-selling brands to curb counterfeiting, top pharma companies say they welcome the regulator's mandate and that they are on track. They also view it as a positive step to ensure patient safety. Sheetal Arora, CEO of Mankind Pharmaceuticals, which has already adopted QR codes in 20 of their products, stated: "We strongly advocate for mandatory implementation of barcodes and QR codes on medicines as this initiative will not only protect patients but also strengthen the integrity of our healthcare system by reducing circulation of counterfeit drugs."

Foreign fund inflows, ICICI Bank and RIL boost markets

Foreign fund inflows, ICICI Bank and RIL boost markets

Rediff.com5 Jun 2025

Eternal was the biggest gainer in the Sensex pack, jumping 4.50 per cent, followed by Power Grid, ICICI Bank, Reliance Industries, UltraTech Cement, Adani Ports, Sun Pharma, ITC and Hindustan Unilever were also among the winners. In contrast, IndusInd Bank, Axis Bank, Bajaj Finserv and Bajaj Finance were among the laggards.

Sensex surges over 769 pts as FMCG, power shares gain

Sensex surges over 769 pts as FMCG, power shares gain

Rediff.com23 May 2025

From the Sensex firms, Eternal, Power Grid, ITC, Bajaj Finserv, Nestle, Axis Bank, Kotak Mahindra Bank and Adani Ports were among the biggest gainers. Sun Pharma was the only laggard, declining nearly 2 per cent.

Sensex sinks 573 pts on global tensions and high crude prices

Sensex sinks 573 pts on global tensions and high crude prices

Rediff.com13 Jun 2025

Sensex sinks 573 pts on global tensions and high crude prices

Sensex ends down 182 points on selling in IT shares

Sensex ends down 182 points on selling in IT shares

Rediff.com30 May 2025

Among Sensex firms, Tech Mahindra, HCL Tech, Asian Paints, NTPC, Infosys, Nestle, Sun Pharma, and Tata Steel were the major laggards. Eternal, State Bank of India, HDFC Bank, Larsen & Toubro, Reliance Industries and Bajaj Finserv were the gainers.

Diabetes Drug Price Drops 90%

Diabetes Drug Price Drops 90%

Rediff.com20 Mar 2025

India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 crore anti-diabetic drug market in India is growing at 9 per cent or so.

Sensex sheds 239 pts on selling in FMCG, auto shares

Sensex sheds 239 pts on selling in FMCG, auto shares

Rediff.com28 May 2025

IndusInd Bank, Nestle, UltraTech Cement, Mahindra & Mahindra, Power Grid, Asian Paints, Sun Pharma and Tech Mahindra were also among the laggards. Bajaj Finance, Bharti Airtel, ICICI Bank, Adani Ports and HCL Tech were among the gainers.

How Kerala Aims to Be India's First Poverty Free State

How Kerala Aims to Be India's First Poverty Free State

Rediff.com14 Jul 2025

Despite facing financial constraints, Kerala has been able to invest in welfare schemes and targeted programmes.

Indian pharma companies bank on 'mother brands' to boost revenue growth

Indian pharma companies bank on 'mother brands' to boost revenue growth

Rediff.com28 Mar 2024

Indian pharma companies are focussing on flagship products or mother brands under which they launch various new combinations to ensure robust revenue growth as well as therapy leadership. An analysis by market research firm Pharmarack showed how such flagship brands have posted strong growth CAGR in the last five years, with some even doubling sales. Sheetal Sapale, vice-president, commercial at Pharmarack, said, "Mother brands are analogous to an aggressive player who has put in a lot of effort during the prime years of life but now continues to silently nurture the brand family to collectively cross newer benchmarks of success."

Sun Pharma's growth pill: Specialising in specialty and scaling in India

Sun Pharma's growth pill: Specialising in specialty and scaling in India

Rediff.com25 Mar 2024

Traction for its specialty portfolio, a strong showing in the domestic market, and better regulatory compliance are positives for the country's largest pharmaceutical (pharma) company, Sun Pharmaceutical Industries. Given the triggers, some brokerages have increased their earnings per share estimates and target price for 2024-25 (FY25). This should sustain the momentum for the stock, which has been one of the major pharma gainers in 2023-24 (FY24), rising 57 per cent. It is currently trading at Rs 1,547 per share.

Sensex gains 318 pts on buying in RIL, L&T

Sensex gains 318 pts on buying in RIL, L&T

Rediff.com27 Mar 2025

From the Sensex pack, Bajaj Finserv, IndusInd Bank, NTPC, Larsen & Toubro, UltraTech Cement, Adani Ports, Bajaj Finance, Power Grid, Zomato, State Bank of India, HDFC Bank and Titan were the biggest gainers. Tata Motors tanked over 5.5 per cent after US President Donald Trump announced he would impose 25 per cent tariffs on imported cars. Sun Pharma, Kotak Mahindra Bank, Bharti Airtel, HCL Tech and Mahindra & Mahindra were also among the laggards.

Jurassic World Rebirth Review: Time Pass

Jurassic World Rebirth Review: Time Pass

Rediff.com4 Jul 2025

As a nothing-better-to-do weekend watch, Jurassic World Rebirth is fine. But the franchise is losing steam, observes Deepa Gahlot.